SHH:688578

Shanghai Allist Pharmaceuticals Co., Ltd. · SHH · Healthcare · CNY · FY for 2025

Figures on this page computed 2026-11-08 13:15 UTC

Last close

n/aCNY

Market data

18.0xP/E
Price / Earnings per Share (diluted)
Source
computed
Taken on
2026-11-08
Reported in
CNY
- computed
- Computed from the filing for 2025
34.6%ROIC
NOPAT / Invested Capital x 100, where NOPAT = Operating Income x (1 - Tax Rate) and Invested Capital = Equity + Total Debt - Cash
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
42.0%Net margin
Net Income / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aFCF margin
We do not hold this figure for this company, so there is nothing to place.
Free Cash Flow / Revenue x 100
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
- Computed from the filing for 2025
0.001Debt/equity
Total Debt / Shareholders' Equity
Source
computed
Taken on
2026-11-08
Reported in
CNY
- Computed from the filing for 2025
- Computed from the filing for 2025
n/aDividend yield
We do not hold this figure for this company, so there is nothing to place.
Source
computed
Taken on
2026-11-08
Reported in
CNY
- computed

Price is the furthest below its sector's middle: 0.34 against 0.36 on the market's range.

What it pays out: n/aWe do not hold this figure for this company, so there is nothing to place.

Five bars, one line

lens 7 of 9

3.86x

5.51x

n/a

0.11x

n/a

SalesProfitFree cash flowDebtPrice

Each bar against this company's own average; the line is that average.

Computed2025

Computed2025

Computed2025

Computed2025

Market datan/a

Each against its own average

3 of 5 read

Except where said otherwise: Computed from the filing for 2025

Sales3.86x
Its own average over 9 years, 1.34B.
Profit5.51x
Its own average over 9 years, 395.5M.
Free cash flown/a
Its own average over 8 years, 116.1M.
Debt0.11x
Its own average over 9 years, 35.6M.
Pricen/a
Its own average over 0 years. Market data

Profit is furthest from its own average, at 5.51 times.

Sales is 3.86 times its own 9-year average; Profit is 5.51 times its own 9-year average; Debt is 0.11 times its own 9-year average.

Every figure in this lens

Except where said otherwise: Computed from the filing for 2025

Sales against its own 9-year average3.86
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
Profit against its own 9-year average5.51
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
Free cash flow against its own 8-year averagen/a
Not held.
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
Debt against its own 9-year average0.11
Source
computed
Statement
income
Fiscal year
2025
Reported in
CNY
Price against its own 0-year averagen/aMarket data
Not held.
Source
market
Reported in
CNY